| Primary |
| Non-small Cell Lung Cancer |
29.0% |
| Head And Neck Cancer |
19.7% |
| Gastrooesophageal Cancer |
8.1% |
| Colorectal Cancer Metastatic |
8.0% |
| Prophylaxis |
5.3% |
| Colorectal Cancer |
4.8% |
| Colon Cancer |
4.0% |
| Oesophageal Carcinoma |
3.4% |
| Squamous Cell Carcinoma |
3.1% |
| Hypertension |
2.1% |
| Pain |
2.0% |
| Nausea |
1.8% |
| Neoplasm Malignant |
1.6% |
| Pancreatic Carcinoma |
1.4% |
| Premedication |
1.3% |
| Gastric Cancer |
1.1% |
| Non-small Cell Lung Cancer Metastatic |
1.0% |
| Breast Cancer Metastatic |
0.9% |
| Rash |
0.7% |
| Constipation |
0.7% |
|
| Vomiting |
13.7% |
| Pulmonary Embolism |
10.8% |
| Thrombocytopenia |
9.6% |
| Pyrexia |
6.3% |
| Sepsis |
5.3% |
| Pneumonia |
5.1% |
| Deep Vein Thrombosis |
5.1% |
| Neutropenia |
4.9% |
| Weight Decreased |
4.3% |
| Syncope |
4.0% |
| Mucosal Inflammation |
3.9% |
| Dyspnoea |
3.8% |
| Decreased Appetite |
3.5% |
| Anaemia |
3.2% |
| Stomatitis |
3.0% |
| Dehydration |
2.8% |
| Dysphagia |
2.8% |
| Thrombosis |
2.8% |
| Febrile Neutropenia |
2.6% |
| Respiratory Failure |
2.6% |
|
| Secondary |
| Non-small Cell Lung Cancer |
18.6% |
| Colorectal Cancer Metastatic |
15.4% |
| Head And Neck Cancer |
11.5% |
| Prophylaxis |
11.4% |
| Drug Use For Unknown Indication |
6.9% |
| Colorectal Cancer |
6.0% |
| Colon Cancer |
5.8% |
| Product Used For Unknown Indication |
3.7% |
| Pain |
3.5% |
| Hypertension |
2.3% |
| Nausea |
2.1% |
| Rectal Cancer |
1.9% |
| Squamous Cell Carcinoma |
1.7% |
| Premedication |
1.5% |
| Squamous Cell Carcinoma Of Head And Neck |
1.3% |
| Pancreatic Carcinoma |
1.3% |
| Colon Cancer Metastatic |
1.3% |
| Metastatic Gastric Cancer |
1.2% |
| Gastric Cancer |
1.2% |
| Metastases To Liver |
1.2% |
|
| Vomiting |
14.5% |
| Pneumonia |
10.4% |
| Pulmonary Embolism |
8.9% |
| Pyrexia |
7.0% |
| Weight Decreased |
6.1% |
| Thrombocytopenia |
5.4% |
| Sepsis |
4.9% |
| Death |
4.3% |
| General Physical Health Deterioration |
3.8% |
| White Blood Cell Count Decreased |
3.7% |
| Dyspnoea |
3.6% |
| Neutropenia |
3.5% |
| Diarrhoea |
3.4% |
| Septic Shock |
3.3% |
| Nausea |
3.1% |
| Pain |
3.0% |
| Dehydration |
2.9% |
| Renal Failure Acute |
2.8% |
| Urinary Tract Infection |
2.8% |
| Hypomagnesaemia |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
15.0% |
| Colorectal Cancer |
13.1% |
| Colorectal Cancer Metastatic |
9.6% |
| Product Used For Unknown Indication |
7.6% |
| Non-small Cell Lung Cancer |
7.2% |
| Colon Cancer |
5.5% |
| Colon Cancer Metastatic |
5.5% |
| Adenocarcinoma Pancreas |
5.3% |
| Prophylaxis |
5.2% |
| Adenocarcinoma |
3.3% |
| Hypertension |
3.1% |
| Rectal Cancer |
2.9% |
| Nausea |
2.8% |
| Pancreatic Carcinoma Non-resectable |
2.4% |
| Squamous Cell Carcinoma |
2.4% |
| Cancer Pain |
2.3% |
| Chemotherapy |
2.3% |
| Metastatic Gastric Cancer |
1.6% |
| Pain |
1.6% |
| Rectal Cancer Metastatic |
1.3% |
|
| Vomiting |
17.0% |
| Pneumatosis Intestinalis |
7.1% |
| Portal Vein Thrombosis |
7.1% |
| Disease Progression |
6.3% |
| Gastrointestinal Ulcer |
6.3% |
| Thrombocytopenia |
5.4% |
| Dehydration |
4.5% |
| Nausea |
4.5% |
| Osteonecrosis |
4.5% |
| Device Occlusion |
3.6% |
| Gouty Arthritis |
3.6% |
| Headache |
3.6% |
| Neoplasm Malignant |
3.6% |
| Off Label Use |
3.6% |
| Pneumonia |
3.6% |
| Pneumonitis |
3.6% |
| Pruritus |
3.6% |
| Varices Oesophageal |
3.6% |
| Haemolytic Uraemic Syndrome |
2.7% |
| Hypersensitivity |
2.7% |
|
| Interacting |
| Myocardial Ischaemia |
100.0% |
|
|
